Literature DB >> 30847745

TRIM27 Promotes Hepatitis C Virus Replication by Suppressing Type I Interferon Response.

Feng Zheng1, Nannan Xu2, Yajun Zhang2.   

Abstract

Type I interferon (IFN) response is central for host defense against viral infection. Tripartite motif 27 (TRIM27) is implicated in antiviral innate immune response; however, whether it affects the replication of hepatitis C virus (HCV) and the underlying mechanisms remain uncharacterized. Here, we show that TRIM27 expression is induced in Huh7.5 human hepatoma cells infected with HCV or stimulated with type I IFNs in vitro. In addition, TRIM27 overexpression increases and its knockdown decreases viral RNA and protein levels, suggesting that TRIM27 positively regulates HCV replication. Mechanistically, TRIM27 inhibits type I IFN response against HCV infection through inhibiting IRF3 and NF-κB pathways, since TRIM27 mutant unable to inhibit these two inflammatory pathways fails to promote HCV replication. Taken together, this study identifies TRIM27 as a novel positive regulator of HCV replication, and also implicates that targeting TRIM27 may serve as a therapeutic strategy for controlling HCV replication.

Entities:  

Keywords:  IRF3; NF-κB; TRIM27; hepatitis C virus; type I interferon response

Mesh:

Substances:

Year:  2019        PMID: 30847745     DOI: 10.1007/s10753-019-00992-5

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  33 in total

Review 1.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

3.  A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons.

Authors:  Kentaro Asaoka; Kazuhiro Ikeda; Toshiki Hishinuma; Kuniko Horie-Inoue; Satoru Takeda; Satoshi Inoue
Journal:  Biochem Biophys Res Commun       Date:  2005-11-11       Impact factor: 3.575

4.  Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.

Authors:  Tobias Marcello; Arash Grakoui; Giovanna Barba-Spaeth; Erica S Machlin; Sergei V Kotenko; Margaret R MacDonald; Charles M Rice
Journal:  Gastroenterology       Date:  2006-10-01       Impact factor: 22.682

Review 5.  Mechanism of action of interferon and ribavirin in treatment of hepatitis C.

Authors:  Jordan J Feld; Jay H Hoofnagle
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

Review 6.  Signaling to NF-kappaB by Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Trends Mol Med       Date:  2007-10-29       Impact factor: 11.951

7.  Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.

Authors:  Zhengfan Jiang; Tak W Mak; Ganes Sen; Xiaoxia Li
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

8.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

Review 9.  TRIM family proteins: retroviral restriction and antiviral defence.

Authors:  Sébastien Nisole; Jonathan P Stoye; Ali Saïb
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

10.  Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Authors:  Alexander Ploss; Matthew J Evans; Valeriya A Gaysinskaya; Maryline Panis; Hana You; Ype P de Jong; Charles M Rice
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

View more
  9 in total

1.  To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.

Authors:  Adam Hage; Ricardo Rajsbaum
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

2.  MicroRNA-324-3p Plays A Protective Role Against Coxsackievirus B3-Induced Viral Myocarditis.

Authors:  Tingjun Liu; Jing Tong; Chen Shao; Junyan Qu; Hua Wang; Yi Shi; Yajing Lin; Yun Liu; Shihe Shao; Hongxing Shen
Journal:  Virol Sin       Date:  2021-10-11       Impact factor: 6.947

3.  Tripartite motif 27 promotes cardiac hypertrophy via PTEN/Akt/mTOR signal pathways.

Authors:  Yan Chen; Zewen Liu; Zhengqing Hu; Xiuyuan Feng; Li Zuo
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 4.  TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense.

Authors:  Ling Wang; Shunbin Ning
Journal:  Viruses       Date:  2021-02-11       Impact factor: 5.818

5.  TRIM27 contributes to glomerular endothelial cell injury in lupus nephritis by mediating the FoxO1 signaling pathway.

Authors:  Jinxi Liu; Jie Xu; Jie Huang; Cunyang Gu; Qingjuan Liu; Wei Zhang; Fan Gao; Yuexin Tian; Xinyan Miao; Zixuan Zhu; Baiyun Jia; Yu Tian; Lunbi Wu; Hang Zhao; Xiaojuan Feng; Shuxia Liu
Journal:  Lab Invest       Date:  2021-04-14       Impact factor: 5.502

Review 6.  Regulation of Tripartite Motif-Containing Proteins on Immune Response and Viral Evasion.

Authors:  Xiu-Zhong Zhang; Fu-Huang Li; Xiao-Jia Wang
Journal:  Front Microbiol       Date:  2021-12-01       Impact factor: 5.640

7.  Crotonylation sensitizes IAPi-induced disruption of latent HIV by enhancing p100 cleavage into p52.

Authors:  Dajiang Li; Morgan G Dewey; Li Wang; Shane D Falcinelli; Lilly M Wong; Yuyang Tang; Edward P Browne; Xian Chen; Nancie M Archin; David M Margolis; Guochun Jiang
Journal:  iScience       Date:  2021-12-18

Review 8.  Emerging roles of TRIM27 in cancer and other human diseases.

Authors:  Chengpeng Yu; Dean Rao; Tiantian Wang; Jia Song; Lei Zhang; Wenjie Huang
Journal:  Front Cell Dev Biol       Date:  2022-09-19

Review 9.  Emerging Roles of MHC Class I Region-Encoded E3 Ubiquitin Ligases in Innate Immunity.

Authors:  Xiuzhi Jia; Chunyuan Zhao; Wei Zhao
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.